Neuroone Medical Technologies CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
NeuroOne Medical Technologies issues a second supplement to its proxy statement to correct the description of the quorum requirements for its upcoming 2025 Annual Meeting of Stockholders.
NASDAQ
NeuroOne Medical Technologies amends its 2025 Equity Incentive Plan to remove the evergreen feature following stockholder feedback, seeking approval at the upcoming annual meeting.
NASDAQ
DEF: NeuroOne Medical Technologies Seeks Stockholder Approval for Reverse Stock Split and New Equity Plan
NeuroOne Medical Technologies is asking shareholders to approve a reverse stock split to maintain its Nasdaq listing and a new equity incentive plan to attract and retain talent.